Brands Henrike Jacoba, Van Dijk Brigit, Brohet Richard M, van Westreenen Henderik L, de Groot Jan Willem B, Moons Leon M G, de Vos Tot Nederveen Cappel Wouter H
Gastroenterology and Hepatology, Isala Hospital, 8025 AB Zwolle, The Netherlands.
Department of Epidemiology and Statistics, Isala Hospital, 8025 AB Zwolle, The Netherlands.
Cancers (Basel). 2023 Mar 28;15(7):2011. doi: 10.3390/cancers15072011.
If Colorectal cancer (CRC) is detected and treated early, the survival rate is high. This is one of the reasons that population-based screening programs for the early detection of CRC using the faecal immunochemical test (FIT) started worldwide. These programs compete with regular colonoscopy programs and increase the waiting time for symptomatic patients. However, the literature has shown that the correlation between intestinal complaints and the gain of colonoscopy is poor. The aim of this study is to assess the diagnostic utility of symptoms for the yield (CRC) of colonoscopy and to compare this with the diagnostic utility of FIT when offered to symptomatic patients.
We performed a systematic review search for CRC as an outcome of colonoscopy in referred symptomatic patients and separately for CRC as an outcome in symptomatic patients with a positive FIT. We searched systematically for clinical trials or observational studies in databases, followed by hand-searching of reference lists. We used random Meta-Disc to evaluate the diagnostic performance, using the exploration of heterogeneity with a variety of test statistics and by computing the pooled estimates.
We included 35 studies, with almost 5 million symptomatic patients. In addition, we included nine prospective studies with a positive FIT in symptomatic patients, with more than 5000 patients. Significant heterogeneity was found for every symptom and the outcome of colonoscopy in the effect size of sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio. In a random effect model, the pooled sensitivity of colonoscopy in symptomatic patients was very low (25%). However, the pooled sensitivity in symptomatic patients with a positive FIT was 83% and the pooled specificity 77%. A total of 75 symptomatic patients (1.4%) had a false-negative FIT.
Adding FIT in symptomatic patients seems useful for predicting CRC as an outcome of colonoscopy. FIT seems a potential tool for an improved triage of colonoscopy in symptomatic patients.
如果早期发现并治疗结直肠癌(CRC),生存率会很高。这就是全球范围内启动基于人群的粪便免疫化学检测(FIT)用于早期检测CRC筛查项目的原因之一。这些项目与常规结肠镜检查项目竞争,增加了有症状患者的等待时间。然而,文献表明肠道症状与结肠镜检查获益之间的相关性较差。本研究的目的是评估症状对结肠镜检查检出率(CRC)的诊断效用,并将其与向有症状患者提供FIT时的诊断效用进行比较。
我们对转诊的有症状患者中结肠镜检查结果为CRC以及FIT阳性的有症状患者中CRC结果进行了系统评价检索。我们系统检索了数据库中的临床试验或观察性研究,随后手动检索参考文献列表。我们使用随机Meta-Disc评估诊断性能,通过多种检验统计量探索异质性并计算合并估计值。
我们纳入了35项研究,涉及近500万例有症状患者。此外,我们纳入了9项有症状患者FIT阳性的前瞻性研究,涉及5000多名患者。在敏感性、特异性、阳性似然比、阴性似然比和诊断比值比的效应大小方面,每种症状与结肠镜检查结果之间均发现显著异质性。在随机效应模型中,有症状患者结肠镜检查的合并敏感性非常低(25%)。然而,FIT阳性的有症状患者的合并敏感性为83%,合并特异性为77%。共有75例有症状患者(1.4%)FIT结果为假阴性。
在有症状患者中增加FIT似乎有助于预测结肠镜检查结果为CRC。FIT似乎是改善有症状患者结肠镜检查分诊的潜在工具。